SARS-CoV-2 anti-spike antibodies after a fourth dose of COVID-19 vaccine in adult solid-organ transplant recipients

BACKGROUND: A fourth dose of SARS-CoV-2 vaccine is recommended in solid-organ transplant (SOT) recipients, but the immunogenicity is poorly known. METHODS: We conducted a retrospective, observational, monocentric study between the 1st January 2021 and 31st March 2022 of the anti-Spike antibody titer...

Descripción completa

Detalles Bibliográficos
Autores principales: Perrier, Quentin, Lupo, Julien, Gerster, Théophile, Augier, Caroline, Falque, Loïc, Rostaing, Lionel, Pelletier, Laurent, Bedouch, Pierrick, Blanc, Myriam, Saint-Raymond, Christel, Boignard, Aude, Bonadona, Agnès, Noble, Johan, Epaulard, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444490/
https://www.ncbi.nlm.nih.gov/pubmed/36184404
http://dx.doi.org/10.1016/j.vaccine.2022.08.065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444490/
https://www.ncbi.nlm.nih.gov/pubmed/36184404
http://dx.doi.org/10.1016/j.vaccine.2022.08.065

Ejemplares similares